Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.78 |
| ▸ | LMNA | P02545 | 5/20 | 0.78 |
| ▸ | MEN1 | O00255 | 4/20 | 0.78 |
| ▸ | TP53 | P04637 | 4/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.78 |
| ▸ | HTT | P42858 | 4/20 | 0.78 |
| ▸ | TSHR | P16473 | 3/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.78 |
| ▸ | APAF1 | O14727 | 3/20 | 0.78 |
| ▸ | USP2 | O75604 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | RAD52 | P43351 | 3/20 | 0.78 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.78 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.78 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.78 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.78 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL120301 | 0.99 | MEN1 (0.78) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| Water SCHEMBL15416925 | 0.99 | SMN1; SMN2 (0.76) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| SCHEMBL3913464 | 0.90 | SMN1; SMN2 (0.76) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| Benzethonium SCHEMBL122985 | 0.87 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| Benzethonium SCHEMBL927612 | 0.86 | SMN1; SMN2 (0.98) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| Benzethonium SCHEMBL22711570 | 0.86 | SMN1; SMN2 (0.98) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| Benzethonium SCHEMBL5549294 | 0.86 | SMN1; SMN2 (0.98) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| Benzethonium SCHEMBL4418328 | 0.86 | SMN1; SMN2 (0.98) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| Benzethonium SCHEMBL1951703 | 0.86 | SMN1; SMN2 (0.98) | SMN1; SMN2LMNAMEN1TP53KMT2A | |
| Benzethonium SCHEMBL1672928 | 0.86 | SMN1; SMN2 (0.98) | SMN1; SMN2LMNAMEN1TP53KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2279736-A1 | Microbicidal and antiparasitic compositions comprising quassinoids or quassionid-containing plant extracts | Life Science Investments Ltd. (GB) | 2011-02-02 | — | — | EP | claimed |
| WO-2002067898-A1 | PROLONGATION OF CHEMICAL ACTIVITY OF FLAVORANTS AND THERAPEUTICS WITH CETYL PYRIDINIUM CHLORIDE | SDG, INC. (US) | 2002-09-06 | — | — | WO | claimed |
| EP-4422572-B1 | ABSORBENT WEB AND ARTICLE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4422572-A1 | ABSORBENT WEB AND ARTICLE | Solventum Intellectual Properties Company (US) | 2024-09-04 | — | — | EP | disclosed |
| US-20240016826-A1 | COMPOSITION, PHARMACEUTICAL COMPOSITION, USE OF A STABLE TOPICAL COMPOSITION COMPRISING A NANOEMULSION AND OF AT LEAST ONE ANTILEISHMANIAL COMPOUND, AND METHOD FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS | FUNDAÇÃO OSWALDO CRUZ (BR) | 2024-01-18 | — | — | US | disclosed |
| EP-4248948-A1 | COMPOSITION, PHARMACEUTICAL COMPOSITION, USE OF A STABLE TOPICAL COMPOSITION COMPRISING A NANOEMULSION AND OF AT LEAST ONE ANTILEISHMANIAL COMPOUND, AND METHOD FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS | Fundação Oswaldo Cruz (BR) | 2023-09-27 | — | — | EP | disclosed |
| WO-2023073497-A1 | ABSORBENT WEB AND ARTICLE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-05-04 | — | — | WO | disclosed |
| US-20210254158-A1 | METHOD FOR PREDICTING A SUBJECTS RESPONSE TO SLC MODULATOR THERAPY | RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. | 2021-08-19 | — | — | US | disclosed |
| WO-2019046303-A1 | A METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-03-07 | — | — | WO | disclosed |
| CN-108472617-A | Include the microcapsules of polyester-urethane shell and hydrophilic nuclear material | 巴斯夫欧洲公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108472616-A | Include the microcapsules of polyester-urethane shell and hydrophobic nuclear material | 巴斯夫欧洲公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-1444471-A | Cosmetic composition | PROCTER & GAMBLE (US) | 2003-09-24 | — | — | CN | disclosed |
| CN-1441665-A | Skin care compositions containing polysilicone elastomers | PROCTER & GAMBLE (US) | 2003-09-10 | — | — | CN | disclosed |
| CN-1420757-A | Improved stannous oral compositions | PROCTER & GAMBLE (US) | 2003-05-28 | — | — | CN | disclosed |
| CN-1418086-A | Stable dentrifice compositions comprising polyphosphate, Fluoride, and stannous | PROCTER & GAMBLE (US) | 2003-05-14 | — | — | CN | disclosed |
| CN-1411343-A | Chewing gum composition | PROCTER & GAMBLE (US) | 2003-04-16 | — | — | CN | disclosed |
| CN-1328441-A | Methods of reducing astringency of stannous in dentifrice compositions | PROCTER & GAMBLE (US) | 2001-12-26 | — | — | CN | disclosed |
| CN-1328442-A | Method for reducing staining of stannous in dentifrice compositions | PROCTER & GAMBLE (US) | 2001-12-26 | — | — | CN | disclosed |
| CN-1238675-A | Dentifrice compositions containing polyphosphate and monofluorophosphate | PROCTER & GAMBLE (US) | 1999-12-15 | — | — | CN | disclosed |
| CN-1237894-A | Dentifrice compositions containing polyphosphate and fluoride | PROCTER & GAMBLE (US) | 1999-12-08 | — | — | CN | disclosed |